1 December 2015
DETAILS
have developed a metabolic ‘toolkit’
that has been successfully
applied to generate novel metabolic pathways to
* bio-derived butadiene and key precursors, such as
* 1,3 butanediol and 2,3 butanediol,
resulting in new direct and 2-step processes
for butadiene utilizing gas-fermentation technology.
A metabolic toolkit
integrates detailed knowledge
about a bacterium’s genetic configuration with the tools
to precisely customize that configuration in order to make
a particular product, together with a model
to accurately predict the performance of the bacterium.
This work is in an early stage of development
with an aim to commercialize within the next several years.
Butadiene,
a key intermediate chemical used in
the production of synthetic rubber and various plastics,
is used by INVISTA in its proprietary,
butadiene-based adiponitrile (ADN) production technologies.
ADN is a critical intermediate chemical
used in the manufacture of nylon 6,6.
INVISTA and LanzaTech first announced
their gas fermentation collaboration efforts in 2012.
Bill Greenfield,
President of INVISTA’s Intermediates business
“This development underscores the progress made on
butadiene production via gas-fermentation technology
as a result of INVISTA’s collaboration with LanzaTech,”
“While we are still early in the process,
we are encouraged by this breakthrough.
Our ongoing collaboration will continue to leverage
the strong biotechnology capabilities
of both LanzaTech and INVISTA.”
Contact
Kim Conlee
+1 316-828-1647
Freya Burton
+1 630-347-8054
WWW.CHEMWINFO.COM BY KHUN PHICHAI
